altretamine and mitomycin

altretamine has been researched along with mitomycin in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19909 (64.29)18.7374
1990's1 (7.14)18.2507
2000's1 (7.14)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bruckner, HW; Butwell, N; Gorbaty, MI; Kalman, J; McKenna, A; Spigelman, M; Storch, J1
Ihde, DC; Viallet, J1
Chahinian, AP; Comis, RL; Hirsh, V; Holland, JF; Kopel, S; Perry, MC; Propert, KJ; Skarin, A; Ware, JH; Zimmer, B1
Livingston, RB1
Ames, MM; McGovern, RM; Miller, KJ1
Brown, JC; Bruckner, HW; Chamberlin, K; Goldberg, J; Storch, JA2
Chahinian, AP; Green, G; Holland, JF1
Broder, LE; Charyulu, KN; Donnelly, EJ; Rao, RK; Raub, WA; Saldana, MJ; Selawry, OS; Sridhar, KS1
Gu, M; Ma, D; Wang, C; Wang, S1
AHRONHEIM, JH1

Reviews

2 review(s) available for altretamine and mitomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Current chemotherapy of small cell lung cancer.
    Chest, 1986, Volume: 89, Issue:4 Suppl

    Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Complement Membrane Attack Complex; Complement System Proteins; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins; Podophyllotoxin; Procarbazine; Prognosis; Time Factors; Vincristine

1986

Trials

3 trial(s) available for altretamine and mitomycin

ArticleYear
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:8

    Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Prognosis; Random Allocation; Remission Induction; Warfarin

1989
Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
    American journal of clinical oncology, 1984, Volume: 7, Issue:5

    Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Thrombocytopenia; Vomiting

1984
A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in
    American journal of clinical oncology, 1994, Volume: 17, Issue:6

    Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Procarbazine; Remission Induction; Vinblastine; Vincristine

1994

Other Studies

9 other study(ies) available for altretamine and mitomycin

ArticleYear
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusion.
    Oncology, 1989, Volume: 46, Issue:6

    Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Fluorouracil; Humans; Infusions, Intravenous; Mitomycin; Mitomycins; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms

1989
Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:8

    Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins

1989
Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines.
    Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:1

    Topics: Altretamine; Animals; Cell Division; Cell Line; Cyclophosphamide; Humans; Male; Microsomes, Liver; Mitomycin; Mitomycins; Neoplasms; Rats; Rats, Inbred Strains; Triazines

1985
Phase II trial of combination chemotherapy of colonic cancer with 5-fluorouracil, mitomycin C, and hexamethylmelamine.
    Oncology, 1983, Volume: 40, Issue:3

    Topics: Altretamine; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Follow-Up Studies; Humans; Mitomycin; Mitomycins; Triazines

1983
Phase II trial of combination chemotherapy for pancreatic cancer with 5-fluorouracil, mitomycin C, and hexamethylmelamine.
    Oncology, 1983, Volume: 40, Issue:3

    Topics: Altretamine; Antibiotics, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Mitomycin; Mitomycins; Pancreatic Neoplasms; Triazines

1983
Comparative study on three chemotherapeutic regimens for the treatment of advanced epithelial ovarian cancer.
    Journal of Tongji Medical University = Tong ji yi ke da xue xue bao, 2000, Volume: 20, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Doxorubicin; Female; Humans; Middle Aged; Mitomycin; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome

2000
Mass blood typing; summary and analysis of the Jackson, Mich., blood typing program.
    Journal of the American Medical Association, 1951, Nov-10, Volume: 147, Issue:11

    Topics: Altretamine; Blood Group Antigens; Blood Grouping and Crossmatching; Carmustine; Humans; Mitomycin

1951